Predict your next investment

HEALTHCARE | Drug Manufacturing / Generics
sxbicon.com

See what CB Insights has to offer

Stage

Private Equity | Alive

Total Raised

$250M

Last Raised

$250M | 10 yrs ago

About Bicon Pharmaceutical Holdings

Bicon Pharmaceutical Holdings makes, sells and distributes pharmaceutical ingredients, modern Chinese medicines, generic drugs, bio-pharmaceuticals and vaccines.

Bicon Pharmaceutical Holdings Headquarter Location

China

Latest Bicon Pharmaceutical Holdings News

PAG Asia Capital Backs Bicon

Feb 28, 2012

PAG Asia Capital Backs Bicon February 28, 2012 By Reuters News Private equity fund PAG Asia Capital has invested $250 million in Bicon Pharmaceutical Holdings, writes Reuters. Weijian Shan, ex-TPG Capital dealmaker, and founder and chief executive of PAG, has been appointed chairman of the board of the new investee company. Reuters – Private equity fund PAG Asia Capital has invested $250 million in unlisted Bicon Pharmaceutical Holdings Co Ltd, a unit of the Chinese pharmaceuticals company said on Tuesday. Weijian Shan, ex-TPG Capital dealmaker, and founder and chief executive of PAG, has been appointed chairman of the eight-member board of Bicon Pharmaceutical, which includes representatives from China Everbright Holdings and Sequoia Capital.

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.